Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
Choong‐kun Lee, Hong Jae Chon, Jaekyung Cheon, Myung Ah Lee, Hyeon-Su Im, Joung-Soon Jang, Min Hwan Kim, Sejung Park, Beodeul Kang, Moonki Hong, Jin Won Kim, Hyung Soon Park, Myoung Joo Kang, Young Nyun Park, Hye Jin Choi
Topics & Concepts
MedicineFOLFOXOxaliplatinGemcitabineInternal medicineTrastuzumabRegimenOncologyFluorouracilGastroenterologyChemotherapyCancerColorectal cancerBreast cancerCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersPancreatic and Hepatic Oncology Research